News
COVID-19 Hospitalizations In The US Drop But Medics Stressed
There are 16,138 people in hospitals with COVID-19 as of April 8, which is the lowest number since the US Department of Health and Human Services began tracking in July 2020. Only 2% of beds are now allocated to COVID-19...
News
CluePoints Continues Impressive Global Growth with Three New Senior Appointments
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has appointed Catherine Ditzler as VP Marketing while Céline Daubresse joins as VP People, and James Faust is the new VP Business Operations.
Catherine brings more...
News
NHS Offers COVID-19 Jab To 5 Million Kids Aged 5-11 Years
As the largest and most successful vaccination effort in health service history continues to the next phase, the NHS has begun inoculating children aged 5-11. Following updated JCVI guidelines, nearly five million children in this age range are entitled to two...
News
COVID-19 Led To Mental Trauma For US High School Students
According to survey results1 published on April 1st and even prior to that by the US Centers for Disease Control and Prevention, mental health concerns amongst high school students in the United States were intensified by the COVID-19 pandemic....
News
1 billion vaccine doses: Emirates SkyCargo surpasses a historic landmark for COVID-19 vaccine transportation
Emirates SkyCargo has transported more than 1 billion doses of COVID-19 vaccines on its aircraft. The air cargo carrier has achieved this historic milestone within a span of 18 months from the first shipment of COVID-19 vaccines trialled in...
News
Allergy Therapeutics Selects AGC Biologics to Manufacture Novel Peanut Allergy Vaccine Candidate
AGC Biologics announced a new partnership with Allergy Therapeutics, the fully integrated specialty pharmaceutical company specializing in allergy vaccines. The CDMO has manufactured phase I clinical trial materials for Allergy Therapeutics’ novel virus-like particle (VLP)-based peanut allergy vaccine candidate...
News
Alcami Expands Biopharma Storage at Masy BioServices
Alcami announced plans to expand its biostorage footprint at Masy BioServices. Joining the company's existing New England campus is a new 160,000 square-foot facility, purpose-built for cGMP pallet storage space at 15°C to 30°C.
"As the preferred provider of cGMP...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.















